StartUs Insights › Blog › Healthcare
Global Cardiology Outlook 2024: Industry Data & New Technologies

Global Cardiology Outlook 2024: Industry Data & New Technologies

Innovations in imaging technologies, minimally invasive procedures, and personalized medicine improve patient outcomes in the cardiology industry. This report analyzes key market data, emerging trends and technologies, and strategic insights for stakeholders in this field worldwide.
Related topics:

The 2024 Cardiology Report details an evolving sector by highlighting trends, key players, and the investments driving growth and invention. The industry attracts top talent and investors worldwide and showcases high growth potential. With many companies addressing different aspects of heart health, this sector drives innovation in new diagnostics, monitoring, and treatment solutions. This report offers insights into the industry’s current landscape and the factors contributing to its sustained expansion.

Also, this cardiology outlook serves as a reference for stakeholders within the industry, investors, policymakers, and economic analysts, providing a snapshot of the industry’s health to map its trajectory for innovation and growth in the coming years.

StartUs Insights Global Cardiology Outlook 2024

Cardiology Outlook 2024 | StartUs Insights

Executive Summary: Heart Health Report 2024

This report is created using data obtained from the Big Data and AI-powered StartUs Insights Discovery Platform, covering more than 4.7 million global companies, as well as 20K+ technologies and emerging trends. We also analyzed a sample of 4000+ cardiology startups developing innovative solutions to present five examples from emerging cardiology industry trends.

  • Industry Growth Overview: The cardiology industry encompasses over 21610 companies. It experienced an annual growth rate of 6.32%.
  • Manpower & Employment Growth: It employs more than 1 million professionals. Moreover, the industry saw an employee growth of over 57K last year.
  • Patents & Grants: The cardiology sector holds 760+ patents and over 410 grants.
  • Global Footprint: The industry’s activities are concentrated in leading hubs in the USA, India, Brazil, the UK, and Germany. Major city hubs include New York City, Bangalore, New Delhi, Mumbai, and Chennai.
  • Investment Landscape: The average investment value per funding round in the cardiology industry is USD 34 million. The sector closed more than 1180 funding rounds, attracting over 430 investors. Further, investments were made in over 440 companies.
  • Top Investors: Top investors funding this sector include Addlife, Deerfield, and Qiming Venture Partners. The combined investments of these top players amount to USD 481 million.
  • Startup Ecosystem: The top innovative startups include Anumana (low ejection fraction (LEF) detection), MediRapp (echocardiography diagnostic software), Cardea Health (patient data analysis), 2ndheart (cardio-simulator platform), and Pacertool (dyssynchronous heart failure treatment).
  • Recommendations for Stakeholders: To capitalize on the growth and innovation in the cardiology industry, investors should continue exploring cardiac devices, new imaging tools, and personalized treatments. Governments should facilitate funding and grants to increase research and development and ensure a supportive regulatory environment. Entrepreneurs must also leverage advancements in technology to address unmet needs in patient care and reach new markets.

Explore the Data-driven Heart Disease Report for 2024

The Cardiology Report 2024 uses data from the Discovery Platform and encapsulates the key metrics that underline the sector’s dynamic growth and innovation. The cardiology industry includes over 21610 companies, with 4003 being startups, highlighting the entrepreneurial activity within this field. The industry experienced an annual growth rate of 6.32%.

With over 760 patents registered, the industry emphasizes research and development. Additionally, the industry benefited from 410 grants, further supporting advancement and innovations. The global workforce in the cardiology industry comprises approximately 1 million professionals, with an employee growth of 57K last year.

The activities are concentrated all around the world with the USA, India, Brazil, the UK, and Germany leading as top country hubs. Within these countries, major city hubs such as New York City, Bangalore, New Delhi, Mumbai, and Chennai stand out as key hubs for startup activity and innovation exchange.

What data is used to create this cardiology future outlook?

Based on the data provided by our Discovery Platform, we observe that the cardiology industry ranks among the top 5% in the following categories relative to all 20K topics in our database. These categories provide a comprehensive overview of the industry’s key metrics and inform the short-term future direction of the industry.

  • News Coverage & Publications: There were 5700+ news articles published about the cardiology industry last year.
  • Funding Rounds: Our database records 1180+ funding rounds and showcases the industry’s appeal to investors.
  • Manpower: The cardiology industry includes more than 1 million workers. It added over 57K new employees last year.
  • Patents: The industry holds more than 760 patents.
  • Grants: This sector received over 410 grants to support research and development in the cardiology sector.
  • Yearly Global Search Growth: The industry saw an 8.27% increase in yearly global search growth reflecting rising interest and engagement worldwide.
  • and more. Get in touch to explore all data points used to create this report on heart disease.

A Snapshot of the Global Cardiology Industry

The global workforce in the cardiology industry stands at approximately 1 million professionals. This number reflects the employee growth of over 57K in the last year alone and indicates the industry’s capacity and demand for skilled professionals. Over 21610 companies operate within the cardiology sector. This diverse range of companies highlights the scope of the industry and its potential for innovation and growth.

Explore the Funding Landscape of the Cardiology Industry

The average investment value per funding round in the cardiology industry is USD 34 million. Moreover, our data shows that the sector closed more than 1180 funding rounds. Also, the cardiology industry attracted more than 430 investors and reflected the interest from various funding sources. These investors collectively invested in over 440 companies to further emphasize the industry’s appeal and diverse opportunities.

Who is Investing in Cardiology Solutions?

The cardiology industry received investments from top investors, with a combined value of over USD 481 million. Here are some key insights:

These top investors contributed to the growth of the cardiology industry through innovation and supporting advancement in this critical sector.

Minimally Invasive Surgery includes a total of about 2530 companies. This trend employs approximately 277K professionals, including 14K new employees added in the last year. The annual trend growth rate stands at 14.57% and reflects the increasing adoption and innovation in surgical techniques that minimize patient recovery time and improve outcomes. 

The 4D Ultrasound sector is growing with 400+ companies. This niche employs around 22800 professionals, with 890+ new employees joining the workforce in the past year. The annual trend growth rate is 7.34% and indicates steady progress and interest in this advanced imaging technology. 

Remote Patient Monitoring encompasses 1890+ companies in this sector and employs approximately 155K professionals. This field saw an addition of 15200 new employees in the last year alone and experienced an annual trend growth rate of 22.42%.

5 Top Examples from 4000+ Innovative Cardiology Startups

The five innovative startups showcased below are picked based on data including the trend they operate within and their relevance, founding year, funding status, and more. Book a platform demo to find promising startups, emerging trends, or industry data specific to your company’s needs and objectives.

Anumana detects Low Ejection Fraction (LEF)

US-based startup Anumana develops the ECG-AI LEF algorithm to detect low left ventricular ejection fraction (LEF) early. The algorithm uses electrocardiograms (ECGs) and echo data pairs. Its deep learning model analyzes these ECG patterns and provides early detection of any heart diseases, improves patient outcomes, and reduces healthcare costs. ECG-AI LEF integrates into electronic health records (EHR) and clinical workflows for efficient use. 

MediRapp builds an Echocardiography Diagnostic Software

Swiss startup MediRapp builds an AI-powered software echocardiography solution, EchoRapp. EchoRapp analyzes and interprets complex clinical data, and provides diagnoses through an interface. The software’s algorithms interpret measurements, images, and data and the software features a patient management system while linking to ultrasound devices. Further, EchoRapp generates detailed medical reports, integrating AI and physician input for clarity. The system offers transparency with detailed references and various measurement functionalities for ultrasound images. 

Cardea Health conducts Patient Data Analytics

Canadian startup Cardea Health leverages natural language processing (NLP) and machine learning (ML) to optimize clinical trial patient identification. Its platform, FLOW, enhances trial outcomes by consolidating patient data into actionable insights. The startup’s WorkFLOW solution provides real-time insights on a unified interface and improves data accessibility. The ScreenFLOW solution matches patients to trials to streamline the enrollment process. Moreover, SearchFLOW streamlines patient data analysis for trial candidates and treatment optimization. FLOW‘s Cardiac Data Lake extracts insights from unstructured data and tailors them for cardiology trials. This suite of solutions assists clinical trials by enhancing efficiency and accuracy in patient matching and data analysis.

2ndheart develops a Cardio-Simulator Platform

UK-based startup 2ndheart provides a pre-operative simulation portal to define optimal therapeutic implications for individual patients. This simulator utilizes predictive analysis systems with advanced AI to interpret patient-specific geometry and pathophysiological features with zero-variability echo analysis. It integrates multidisciplinary approaches, including tissue engineering, fluorescence spectroscopy, bioinformatics, and computer science. Also, it offers ex vivo modeling to provide deep quantitative and qualitative insights on valvular biomechanics. Applications include rheumatic fever, mitral regurgitation, and mitral valve prolapse. 

Pacertool assists in Dyssynchronous Heart Failure Treatment

Norwegian startup Pacertool assists in the treatment of dyssynchronous heart failure with its proprietary medical device designed to optimize pacemaker treatments. The PaCRTool System quantifies the heart’s resynchronization potential in real-time during pacemaker implantation. Its PreSens Catheter measures an electromechanical biomarker to determine optimal pacemaker placement. This single-use catheter provides invasive measurements of dyssynchrony and heart failure diagnosis. Also, the system supports physiological pacing and preserves cardiac function during treatment.

Gain Comprehensive Insights into Cardiology Trends, Startups, or Technologies

In conclusion, the 2024 Cardiology Industry Report highlights the innovation within this essential healthcare sector. Despite facing challenges, the industry demonstrated strength through investments and substantial workforce expansion. Key areas such as cardiac device advancements, non-invasive imaging techniques, and personalized treatment approaches highlight the developments. The continued support from top investors and the emergence of startups reflect the nature of cardiology. Contact us to explore all 4000+ startups and scaleups, as well as all industry trends impacting cardiology companies.

Industry Report CTA Visual